What are the treatment options for major depressive disorder (MDD) in adolescents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Treatment for depression in adolescents typically involves a combination of psychotherapy and sometimes medication, with Cognitive Behavioral Therapy (CBT) as the first-line treatment and selective serotonin reuptake inhibitors (SSRIs) like fluoxetine (Prozac) prescribed for moderate to severe depression, as recommended by the Guidelines for Adolescent Depression in Primary Care (GLAD-PC) 1.

Key Components of Treatment

  • Psychotherapy: CBT is often the first-line treatment, helping teens identify negative thought patterns and develop coping strategies.
  • Medication: SSRIs like fluoxetine may be prescribed for moderate to severe depression, usually starting at 10mg daily and potentially increasing to 20mg after 1-2 weeks.
  • Family Involvement: Family involvement in treatment is crucial, as is creating a supportive home environment.
  • Lifestyle Changes: Regular exercise, healthy sleep habits, and strong social connections also support recovery.

Important Considerations

  • Monitoring for side effects: Parents should monitor for side effects including increased suicidal thoughts, especially in the first few weeks.
  • Treatment duration: Treatment typically continues for at least 6-12 months after symptom improvement.
  • Collaborative care: A collaborative care approach, which includes regular follow-up with depression care managers, can be effective in reducing depressive symptoms and improving treatment outcomes 1.

From the FDA Drug Label

Sertraline treatment should be initiated with a dose of 50 mg once daily in adolescents (ages 13 to 17) While a relationship between dose and effect has not been established for OCD, patients were dosed in a range of 25 to 200 mg/day in the clinical trials demonstrating the effectiveness of sertraline for pediatric patients (6 to 17 years) with OCD. Patients not responding to an initial dose of 25 or 50 mg/day may benefit from dose increases up to a maximum of 200 mg/day

The treatment for depression in adolescents with sertraline is to initiate with a dose of 50 mg once daily. However, the provided text does not directly address the treatment of depression in adolescents, but rather mentions the dosage for Obsessive-Compulsive Disorder (OCD).

  • The dose may be increased up to a maximum of 200 mg/day if the patient does not respond to the initial dose.
  • It is essential to note that the text does not provide direct information on the treatment of depression in adolescents, and the information provided is based on the treatment of OCD in this age group 2.

From the Research

Treatment Options for Adolescent Depression

  • Medication monotherapy, specifically with selective serotonin reuptake inhibitors (SSRIs), is supported by large clinical trials in adolescents 3
  • Cognitive behavior therapy (CBT) and interpersonal therapy are reasonable options as monotherapies for mild to moderate depression 3
  • Combination of medication and CBT is superior to medication alone for accelerating treatment response and remission 3, 4, 5

Effectiveness of Psychological Therapies and Antidepressant Medication

  • Psychological therapies and antidepressant medication are both effective in treating depressive disorders in children and adolescents, with no significant differences between the two 4, 6
  • Combination therapy is more effective than antidepressant medication alone in achieving higher remission rates 4, 5, 6
  • CBT, interpersonal psychotherapy, and collaborative care programs are classified as well-established treatments for adolescent depression 7

Considerations for Treatment

  • Treatment response varies across disorders (anxiety versus depression) and patient characteristics, such as age, symptom severity, and presence of externalizing disorders 5
  • The added value of CBT with an SSRI occurs late in treatment, highlighting the importance of ongoing therapy 5
  • Combined treatment may be better than either psychotherapy or pharmacotherapy alone, especially for patients with severe symptoms or complex presentations 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Child and adolescent depression intervention overview: what works, for whom and how well?

Child and adolescent psychiatric clinics of North America, 2012

Research

Evidence-Base Update of Psychosocial and Combination Treatments for Child and Adolescent Depression.

Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.